Changes reflect increasing antibiotic resistance for some infections and new treatment options for others. The CDC has issued a new set of sexually transmitted disease (STD) treatment guidelines that ...
Neither treatment group had bacterial persistence of urogenital Neisseria gonorrhoeae at test-of-cure. HealthDay News — For uncomplicated urogenital gonorrhea, gepotidacin, which inhibits bacterial ...
Please provide your email address to receive an email when new articles are posted on . A week-long regimen of doxycycline was superior to a single-dose of azithromycin for the treatment of rectal ...
Background: Centers for Disease Control and Prevention guidelines recommend azithromycin or doxycycline for treatment of rectal chlamydial infection. Methods: We created a retrospective cohort of male ...
Chlamydia treatment may fail twice due to bacterial resistance to antibiotics, such as doxycycline, issues with the absorption of medication into the body, or not following the full course of ...
A commonly prescribed antibiotic used to treat sexually transmitted infections and other conditions is facing a shortage after President Trump promoted it as a potential coronavirus treatment. Demand ...
Nine drug manufacturers told the U.S. Food and Drug Administration that they're experiencing a shortage of azithromycin, an antibiotic better known by its brand name Z-Pack, after President Donald ...
Asha Bowen receives funding from National Health and Medical Research Council, Medical Research Futures Fund, Healthway and WA Government Future Health Research and Innovation Fund. Antibiotic ...
The United States is experiencing a “steep and sustained” spike in sexually transmitted diseases, a new government analysis shows. Cases of gonorrhea, syphilis and chlamydia all increased in 2017, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results